Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Charles River Laboratories International has completed the acquisition of privately held NewLab BioQuality, a Germany-based provider of safety and quality control services to biopharmaceutical clients.
Subscribe to our email newsletter
NewLab joins Charles River Biopharmaceutical Services, which provides services to support the development and manufacture of biologics.
James Foster, chairman, president and CEO of Charles River, said: “The acquisition of NewLab further strengthens our portfolio of essential products and services to help our clients accelerate drug development.
“NewLab enhances the scientific depth, geographic scope and client base of Charles River’s global biopharmaceutical services offering to support the rapidly growing market for biologic drug compounds.”